Christopher James Frankenfield
CIK 1988344 · View on SEC EDGAR ↗
First SEC filing: Aug. 7, 2023 · Latest: Aug. 7, 2023
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | XLO | S 10b5-1 | 7,030 | $0.64 | $4,499 | 24,766 Direct | -22.11% | Disposed | 1.8% (price as of 2026-08-21) |
| Jan. 2, 2025 | XLO | S 10b5-1 | 6,954 | $0.98 | $6,815 | 12,421 Direct | -35.89% | Disposed | -33.5% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 1, 2026 | XLO | Restricted Stock Units | Common Stock (19,375) | — | — | 19,375 | Disposed |
| Dec. 31, 2025 | XLO | Stock Option (right to buy) | Common Stock (668,789) | $0.84 | Oct. 7, 2035 | 668,789 | Acquired |
| Nov. 21, 2025 | XLO | Stock Option (right to buy) | Common Stock (300,000) | $1.50 | Aug. 15, 2033 | 300,000 | Acquired |
| Nov. 21, 2025 | XLO | Stock Option (right to buy) | Common Stock (300,000) | $2.78 | Aug. 15, 2033 | 300,000 | Disposed |
| Nov. 21, 2025 | XLO | Stock Option (right to buy) | Common Stock (150,000) | $1.50 | Aug. 2, 2033 | 150,000 | Acquired |
| Nov. 21, 2025 | XLO | Stock Option (right to buy) | Common Stock (150,000) | $2.75 | Aug. 2, 2033 | 150,000 | Disposed |
| Nov. 21, 2025 | XLO | Stock Option (right to buy) | Common Stock (117,000) | $1.50 | Dec. 31, 2032 | 117,000 | Acquired |
| Nov. 21, 2025 | XLO | Stock Option (right to buy) | Common Stock (117,000) | $2.69 | Dec. 31, 2032 | 117,000 | Disposed |
| Nov. 21, 2025 | XLO | Stock Option (right to buy) | Common Stock (20,000) | $1.50 | Aug. 31, 2032 | 20,000 | Acquired |
| Nov. 21, 2025 | XLO | Stock Option (right to buy) | Common Stock (20,000) | $2.13 | Aug. 31, 2032 | 20,000 | Disposed |
| Nov. 21, 2025 | XLO | Stock Option (right to buy) | Common Stock (45,000) | $1.50 | Feb. 21, 2032 | 45,000 | Acquired |
| Nov. 21, 2025 | XLO | Stock Option (right to buy) | Common Stock (45,000) | $12.66 | Feb. 21, 2032 | 45,000 | Disposed |
| Nov. 21, 2025 | XLO | Stock Option (right to buy) | Common Stock (37,296) | $1.50 | Oct. 20, 2031 | 37,296 | Acquired |
| Nov. 21, 2025 | XLO | Stock Option (right to buy) | Common Stock (37,296) | $16.00 | Oct. 20, 2031 | 37,296 | Disposed |
| Nov. 21, 2025 | XLO | Stock Option (right to buy) | Common Stock (23,786) | $1.50 | March 31, 2031 | 23,786 | Acquired |
| Nov. 21, 2025 | XLO | Stock Option (right to buy) | Common Stock (23,786) | $6.65 | March 31, 2031 | 23,786 | Disposed |
| Nov. 21, 2025 | XLO | Stock Option (right to buy) | Common Stock (155,090) | $1.50 | March 28, 2031 | 155,090 | Disposed |
| Nov. 21, 2025 | XLO | Stock Option (right to buy) | Common Stock (155,090) | $6.65 | March 28, 2031 | 155,090 | Disposed |
| Nov. 21, 2025 | XLO | Stock Option (right to buy) | Common Stock (925,000) | $0.84 | Oct. 7, 2035 | 925,000 | Acquired |
| Jan. 1, 2025 | XLO | Restricted Stock Units | Common Stock (19,375) | — | — | 19,375 | Disposed |
| Jan. 1, 2025 | XLO | Stock Option (right to buy) | Common Stock (251,000) | $0.96 | Dec. 31, 2035 | 251,000 | Acquired |
| Aug. 3, 2024 | XLO | Stock Option (right to buy) | Common Stock (52,000) | $0.90 | Aug. 2, 2034 | 52,000 | Acquired |
| May 1, 2024 | XLO | Stock Option (right to buy) | Common Stock (208,000) | $1.08 | April 30, 2034 | 208,000 | Acquired |
| Jan. 1, 2024 | XLO | Restricted Stock Units | Common Stock (77,500) | — | — | 77,500 | Acquired |
| Aug. 16, 2023 | XLO | Stock Option (right to buy) | Common Stock (300,000) | $2.78 | Aug. 15, 2033 | 300,000 | Acquired |
| Aug. 3, 2023 | XLO | Stock Option (Right to Buy) | Common Stock (150,000) | $2.75 | Aug. 2, 2033 | 150,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 6 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Aug. 7, 2023 | XLO | Stock Option (right to buy)→ Common Stock (155,090) | 155,090 | Direct |
| Aug. 7, 2023 | XLO | Stock Option (right to buy)→ Common Stock (23,786) | 23,786 | Direct |
| Aug. 7, 2023 | XLO | Stock Option (right to buy)→ Common Stock (37,296) | 37,296 | Direct |
| Aug. 7, 2023 | XLO | Stock Option (right to buy)→ Common Stock (45,000) | 45,000 | Direct |
| Aug. 7, 2023 | XLO | Stock Option (right to buy)→ Common Stock (20,000) | 20,000 | Direct |
| Aug. 7, 2023 | XLO | Stock Option (right to buy)→ Common Stock (117,000) | 117,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $533,100 | $106,620 | — | — | $287,874 | — | $14,000 | $3,229,346 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.